The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides ... via an autoinjector. The FDA approval was based on data from ...

FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

Many individuals, particularly those above 60, have the shared objective of losing weight. With age, the task usually becomes more daunting because of a slowing metabolism, making it harder to ...

In the quest for effective weight loss solutions, countless products flood the market, each promising remarkable results.

The condition is largely associated with obesity and an unhealthy diet and lifestyle ... the race to bring a NASH drug to market, but its hopes were dashed after the FDA rejected its marketing ...

In today's health-conscious society, maintaining optimal prostate health is paramount for men, particularly as they age.

With scientific research backing and real user testimonials, Mitolyn offers a compelling option for individuals looking to ...

Thousands of Americans are diagnosed every year with Parkinson’s Disease. It’s a movement disorder that affects the central ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...